Mologic is proud to be a signatory on BIVDA’s industry declaration on tackling Antimicrobial Resistance to coincide with World Antibiotic Awareness Week.
The importance of in vitro diagnostics (IVDs) in tackling the antimicrobial resistance (AMR) challenge cannot be overstated.
The widespread use of broad-spectrum antibiotics has helped to create multi-drug resistant strains of bacteria.
Greater adoption of IVDs would lead to a reduction in cases of unnecessary antibiotic prescribing.
Mologic continues to invest in developing innovative new diagnostics which will help guide clinicians in the most appropriate use of antibiotics, leading the way on demonstrating the value of IVDs in tackling the threat of AMR to human health.